Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/5164
Title: | Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer |
Authors: | Colombo, A. L.;de Almeida Júnior, J. N.;Slavin, M. A.;Chen, Sharon C-A.;Sorrell, Tania |
WSLHD Author: | Chen, Sharon C-A.;Sorrell, Tania C. |
Subjects: | Infectious Diseases and Microbiology |
Issue Date: | 2017 |
Citation: | The Lancet Infectious Diseases 17(11):e344-e356, 2017 |
Abstract: | Critically ill patients and patients with haematological cancer are HIV-negative populations at high risk of invasive fungal infections. In intensive-care units, candidaemia and intra-abdominal candidiasis predominate, but aspergillosis has emerged as a lethal, under-recognised cause of pneumonia. In patients with haematological malignancies or who have undergone stem-cell transplantations, pulmonary disease due to aspergillus and other mould diseases predominate. In this Series paper, we provide an update on risk assessment, new diagnostic strategies, and therapeutic approaches. New concepts have emerged for use of risk prediction rules and an evidence base now exists for inclusion of biomarkers (eg, galactomannan, 1,3-β-D-glucan, and PCR assays for Aspergillus spp) into early diagnostic and therapeutic strategies. Imaging techniques remain helpful for early diagnosis of pulmonary mould diseases, with PET techniques offering potential improvements in diagnostic specificity and evaluation of clinical response. Echinocandins and triazoles have been validated extensively for prophylaxis, empirical therapy, and targeted therapy, but an increase in intrinsically resistant fungi and emergence of secondary resistance as a result of drug-induced selection pressure are of major concern. Echinocandins remain a major component of treatment of invasive candidiasis and new triazoles are the best alternative for prophylaxis and therapy of invasive aspergillosis. |
URI: | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/5164 |
DOI: | https://doi.org/10.1016/S1473-3099(17)30304-3 |
Journal: | The Lancet Infectious Diseases |
Type: | Journal Article |
Study or Trial: | Review |
Department: | Center for Infectious Diseases & Microbiology Laboratory Services |
Facility: | Blacktown Westmead Auburn Mental Health, Cumberland ICPMR |
Keywords: | Antifungal Agents Biomarkers Candida Echinocandins Fungi Hematologic Neoplasms Invasive Fungal Infections Positron-Emission Tomography Triazoles |
Appears in Collections: | Blacktown Mount Druitt Hospital |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.